Skip to main content
$237.88 $1.19 (0.5%)

04:00 PM EDT on 10/15/21

Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 3 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Current Price $237.88 Mkt Cap $215.7B
Open $237.42 P/E Ratio 35.58
Prev. Close $237.88 Div. (Yield) $3.40 (1.4%)
Daily Range $235.82 - $239.30 Volume 2,598,357
52-Wk Range $129.21 - $275.87 Avg. Daily Vol. 2,628,673

Caps

How do you think NYSE:LLY will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,221 Outperform
100 Underperform
 

All-Star Players

238 Outperform
11 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:LLY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Teacherman333 (71.48)
Submitted June 01, 2013

For reference point and to allow for comments by others. As of the end of March, 2013.ROE 31.07%Trailing PE 12.78PB 3.92Div yield 3.60%

einzling44 (22.22)
Submitted May 15, 2012

cap spending ahead

Recent Community Commentary

Read the most recent pitches from players about LLY.

Recs

0
Member Avatar TMFkodyk123 (22.31) Submitted: 8/21/2021 4:30:49 PM : Outperform Start Price: $272.30 NYSE:LLY Score: -12.72

Eli Lilly's top-notch diabetes drug portfolio led by Trulicity, as well as its plaque psoriasis and psoriatic arthritis blockbuster Taltz should lead to mid-teen annual earnings growth in the foreseeable future. While Eli Lilly isn't a bargain buy at 34 times this year's earnings forecast, its growth prospects make up for its price.

Recs

0
Member Avatar jansmath3 (43.62) Submitted: 1/10/2021 9:18:41 PM : Outperform Start Price: $164.96 NYSE:LLY Score: +26.31

This is going to be a big year for pharma

Recs

0
Member Avatar Dividends500 (83.20) Submitted: 12/31/2020 12:27:16 AM : Outperform Start Price: $163.73 NYSE:LLY Score: +8.83

Dividends500 tracks the healthiest dividends in the S&P 500.

To qualify for the portfolio, the company must meet three simple requirements:

- Member of the S&P 500
- Payout ratio below 50%
- Dividend growth year over year

Leaderboard

Find the members with the highest scoring picks in LLY.

Score Leader

harryhotspur1403

harryhotspur1403 (65.89) Score: +685.81

The Score Leader is the player with the highest score across all their picks in LLY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
harryhotspur1403 65.89 10/10/2008 10/14/2011 Outperform 1Y $19.63 +1,112.46% +426.64% +685.81 0 Comment
juliehowe 68.81 10/28/2008 Outperform 1Y $19.88 +1,096.83% +420.69% +676.14 0 Comment
TwinDeltaTandem 69.49 10/28/2008 Outperform 3Y $19.88 +1,096.83% +420.69% +676.14 0 Comment
srdreyer 47.70 10/28/2008 Outperform 1Y $19.75 +1,104.60% +430.84% +673.76 0 Comment
nobigwhoop 74.83 10/20/2008 Outperform NS $20.85 +1,041.36% +377.87% +663.49 0 Comment
hdenoel2 57.80 9/24/2009 12/22/2014 Outperform 5Y $22.03 +979.98% +318.81% +661.16 0 Comment
Chiownknee2 < 20 10/20/2008 Outperform 5Y $20.86 +1,040.74% +379.83% +660.91 0 Comment
darrylbrizan 89.14 10/13/2008 Outperform 5Y $20.80 +1,043.82% +383.97% +659.85 0 Comment
ARGTANGO 26.84 10/13/2008 Outperform 1Y $20.80 +1,043.82% +383.97% +659.85 0 Comment
tunsfool 86.79 10/13/2008 Outperform 5Y $20.80 +1,043.82% +383.97% +659.85 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for LLY.